Indonesia partners with Xuzhou Medical University on digital medicine lab
00:00
00:00
- Indonesia’s Health Ministry and Xuzhou Medical University have signed an agreement to establish a China–Indonesia joint laboratory focused on digital medicine and proactive health.
- The cooperation follows a broader Indonesia–China health MoU signed in Beijing in November 2024 and includes work on medical AI, health information systems and standardization.
- Indonesia is also pushing for technology transfer, domestic capacity building and health data sovereignty, alongside efforts to accelerate TB control and strengthen primary care.
Indonesia’s Ministry of Health and Xuzhou Medical University (XZMU) in China’s Jiangsu province have agreed to establish the China–Indonesia Joint Laboratory for Digital Medicine and Proactive Health.
The agreement was formalized in a Memorandum of Agreement (MoA) between the ministry and XZMU on the creation of the joint laboratory, witnessed by Indonesian Vice Health Minister Benjamin Paulus Octavianus.
“This cooperation is an important foundation for developing digital health systems and deploying medical AI to improve the quality and access of health services for Indonesians,” Benjamin said in a written statement received by Antara in Beijing on Wednesday.
The initiative follows a memorandum of understanding (MoU) between the Indonesian and Chinese governments on health cooperation and medical standardization, signed in Beijing on Nov. 9, 2024, and witnessed by President Prabowo Subianto and President Xi Jinping.
Benjamin visited China from Jan. 15 to 18, 2026, with stops in three cities: Xuzhou in Jiangsu province, Hefei in Anhui province and Hangzhou in Zhejiang province.
The trip aimed to strengthen international cooperation in the health sector, particularly in research and laboratory studies, health information systems, medical artificial intelligence technology, education and the development of health facilities, as well as the standardization of the medical device industry.
“This collaboration is a strategic step to accelerate the transformation of the national health system by strengthening research and using safe, standardized digital and medical AI technologies that are oriented to public needs,” Benjamin added.
As part of the visit, the Indonesian delegation also reviewed the application of AI technology in primary health services and the development of tuberculosis diagnostics using Molecular Rapid Test (TCM)-based tools.
“The Indonesian government encourages technology transfer and the strengthening of the domestic medical device industry, including plans to develop TCM production facilities in Indonesia,” Benjamin said.
The vice minister stressed that all forms of international health cooperation would prioritize technology transfer, national capacity building and the protection and sovereignty of health data.
The working visit is expected to lay the groundwork for sustainable Indonesia–China cooperation in developing digital technology-based health innovation, while also strengthening national research capacity to support priority health programs, including faster tuberculosis elimination and stronger primary healthcare services.
Indonesianpost.com | Antara